Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Levy

Showing results (11-20 of 254) with videos related to

Pageof 26
Sort By:
Expert Opinion on Drug Discovery|March 16, 2013
Lipoxins, resolvins and protectins: new leads for the treatment of asthmaOliver Haworth, Bruce D Levy
Expert Review of Clinical Immunology|June 5, 2013
Lipoxin A4: a new direction in asthma therapy?Cindy Barnig, Bruce D Levy
Future Lipidology|September 28, 2011
Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signalingAnna Planaguma, Bruce D Levy
American Journal of Respiratory Cell and Molecular Biology|September 23, 2006
Lipid mediators as agonists for the resolution of acute lung inflammation and injuryCaroline Bonnans, Bruce D Levy
Cell Biochemistry and Biophysics|June 27, 2021
Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDSJulie Nijmeh, Bruce D Levy
European Journal of Pharmacology|November 8, 2015
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationMelody G Duvall, Bruce D Levy
The Journal of Clinical Investigation|May 15, 2018
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediatorsCharles N Serhan, Bruce D Levy
F1000Research|May 10, 2016
Recent advances in understanding and treating ARDSRebecca M Baron, Bruce D Levy
Annual Review of Physiology|September 20, 2024
Proresolving Lipid Mediators in the Respiratory SystemCharles N Serhan, Bruce D Levy
Nature Reviews. Immunology|December 22, 2015
Specialized pro-resolving mediators: endogenous regulators of infection and inflammationMaria C Basil, Bruce D Levy
Pageof 26

Showing results (11-20 of 254) with videos related to

Sort By:
Pageof 26
Expert Opinion on Drug Discovery|March 16, 2013
Lipoxins, resolvins and protectins: new leads for the treatment of asthmaOliver Haworth, Bruce D Levy
Expert Review of Clinical Immunology|June 5, 2013
Lipoxin A4: a new direction in asthma therapy?Cindy Barnig, Bruce D Levy
Future Lipidology|September 28, 2011
Uncontrolled airway inflammation in lung disease represents a defect in counter-regulatory signalingAnna Planaguma, Bruce D Levy
American Journal of Respiratory Cell and Molecular Biology|September 23, 2006
Lipid mediators as agonists for the resolution of acute lung inflammation and injuryCaroline Bonnans, Bruce D Levy
Cell Biochemistry and Biophysics|June 27, 2021
Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDSJulie Nijmeh, Bruce D Levy
European Journal of Pharmacology|November 8, 2015
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationMelody G Duvall, Bruce D Levy
The Journal of Clinical Investigation|May 15, 2018
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediatorsCharles N Serhan, Bruce D Levy
F1000Research|May 10, 2016
Recent advances in understanding and treating ARDSRebecca M Baron, Bruce D Levy
Annual Review of Physiology|September 20, 2024
Proresolving Lipid Mediators in the Respiratory SystemCharles N Serhan, Bruce D Levy
Nature Reviews. Immunology|December 22, 2015
Specialized pro-resolving mediators: endogenous regulators of infection and inflammationMaria C Basil, Bruce D Levy
Pageof 26